This company seems to have been delisted
Reason: Filed for bankruptcy
Source: https://www.fiercebiotech.com/biotech/vbi-vaccines-secures-court-protection-it-restructures-seeks-buyers
Reason: Filed for bankruptcy
Source: https://www.fiercebiotech.com/biotech/vbi-vaccines-secures-court-protection-it-restructures-seeks-buyers
VBI Vaccines
VBIV
₹5.66
Share price
0.00%
Change (1 day)
-88.92%
Change (1 year)
Categories
Earnings for VBI Vaccines (VBIV)
Earnings in 2024 (TTM): -₹6.86 Billion
According to VBI Vaccines 's latest financial reports the company's current earnings are ₹9.41 Million. In 2023 the company made an earning of -₹8.05 Billion, an increase over its 2022 earnings that were of -₹9.82 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for VBI Vaccines from 1998 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -₹6.86 Billion | -14.77% |
| 2023 | -₹8.05 Billion | -18.06% |
| 2022 | -₹9.82 Billion | 62.43% |
| 2021 | -₹6.05 Billion | 50.88% |
| 2020 | -₹4.01 Billion | -15.66% |
| 2019 | -₹4.75 Billion | -13.82% |
| 2018 | -₹5.52 Billion | 61.32% |
| 2017 | -₹3.42 Billion | 57.8% |
| 2016 | -₹2.17 Billion | -67.39% |
| 2015 | -₹6.64 Billion | 1527.36% |
| 2014 | -₹0.41 Billion | 36.21% |
| 2013 | -₹0.3 Billion | -63.91% |
| 2012 | -₹0.83 Billion | -59.19% |
| 2011 | -₹2.04 Billion | 227.23% |
| 2010 | -₹0.63 Billion | 1741.53% |
| 2009 | -₹33.75 Million | 14.52% |
| 2008 | -₹29.48 Million | -42.93% |
| 2007 | -₹51.65 Million | 21.8% |
| 2006 | -₹42.41 Million | 172.39% |
| 2005 | -₹15.57 Million | 115.38% |
| 2004 | -₹7.23 Million | -42.27% |
| 2003 | -₹12.52 Million | 109.27% |
| 2002 | -₹5.99 Million | 17.89% |
| 2001 | -₹5.08 Million | -369.64% |
| 2000 | ₹1.88 M | -69.24% |
| 1999 | ₹6.11 M | 12.77% |
| 1998 | ₹5.42 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | -₹1.58 Billion | -78.12% | 🇺🇸 USA |
 Myriad Genetics MYGN | -₹10.73 Billion | 49.18% | 🇺🇸 USA |
 Curis CRIS | -₹3.51 Billion | -51.24% | 🇺🇸 USA |